Optimizing gastric cancer treatment: the role of LODDs in lymph node staging - Summary - MDSpire

Optimizing gastric cancer treatment: the role of LODDs in lymph node staging

  • By

  • Zhao Hao

  • Haiyan Niu

  • Yuebo Bi

  • Qimin Sun

  • Wenjun Yang

  • June 9, 2026

  • 0 min

Share

Objective:

To compare the prognostic value of AJCC-N, LNR, and LODDs in gastric adenocarcinoma, emphasizing the need for external validation.

Key Findings:
  • AJCC-N, LNR, and LODDs were strongly correlated across datasets (P < 0.001), indicating their relevance in clinical settings.
  • LODDs showed slightly larger AUCs than LNR and AJCC-N for predicting 1-, 3-, and 5-year survival, suggesting its superior predictive capability.
  • Multivariable Cox regression identified LODDs, sex, age, race, T stage, and tumor size as independent risk factors for overall survival, highlighting the importance of these factors.
Interpretation:

LODDs reflects metastatic tumor burden and demonstrates favorable prognostic performance compared to AJCC-N and LNR, potentially guiding treatment decisions.

Limitations:
  • Further validation in well-defined lymphadenectomy cohorts is warranted, and potential biases or confounding factors should be considered.
Conclusion:

The LODDs-based nomogram may serve as a useful tool for individualized prognostic assessment.

Original Source(s)

Related Content